The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma.
Kuang-Den ChenChien-Ning HsuYi-Ju WuChi Hsiang ChuKuang-Tzu HuangMing-Chao TsaiKing-Wah ChiuBen-Chung ChengChien-Hua ChiuChao-Long ChenChih-Che LinPublished in: Diagnostics (Basel, Switzerland) (2021)
Increasing evidence has suggested that elevated systemic inflammation with a high neutrophil-lymphocyte ratio (NLR) is associated with poor prognosis after liver transplantation (LT). The ongoing molecular events involved in poor survival remain unclear. This retrospective study evaluated LT recipients whose data was collected at Kaohsiung Chang Gung Memorial Hospital between 2005 and 2014. Clinical records of 347 patients with hepatocellular carcinoma from seven days before LT to 30 days after LT illustrated that longitudinal values of lymphocytes, RBC, and hemoglobin were persistently low in patients with peritransplant high NLR (PTH-NLR, pre-LT ≥ 4 and post-LT ≥ 5), which indicated a significantly worse survival rate in association with increased RDW-CV and pancytopenia when compared to other patients (p = 0.008). We further found that PTH-NLR patients had decreased DNA damage response (DDR) genes and detoxifying enzymes of ADH and ALDH families, and increased mitochondrial stress response genes in their liver tissues. Reduced lineage markers of liver progenitor cells were also observed in PTH-NLR patients signifying the presence of unresolved impairments after LT. Our results demonstrate the association between hematopoietic deficiencies and lack of protection against DDR with PTH-NLR in LDLT recipients with HCC and may imply abnormal hematological and organismal defects in those patients.
Keyphrases
- end stage renal disease
- poor prognosis
- ejection fraction
- newly diagnosed
- dna damage response
- chronic kidney disease
- peritoneal dialysis
- gene expression
- healthcare
- long non coding rna
- emergency department
- patient reported outcomes
- dna methylation
- machine learning
- kidney transplantation
- cross sectional
- electronic health record
- artificial intelligence
- transcription factor
- peripheral blood
- adverse drug